Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart C Gordon

Showing results (31-40 of 214) with videos related to

Pageof 22
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2022
Response to: 'No impact of Covid-19 pandemic on decompensation of alcoholic liver disease: Results from a single Center in Milan'Humberto C Gonzalez, Loralee B Rupp, Sheri Trudeau, et al.
Hepatology (Baltimore, Md.)|July 27, 2022
Letter to the editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antiviralsSheri Trudeau, Vivek Mendiratta, Yara Dababneh, et al.
Digestive Diseases and Sciences|November 14, 2007
Bioelectrical impedance analysis for the evaluation of hepatic fibrosis in patients with chronic hepatitis C infectionFadi Antaki, M Margaret French, Dilip K Moonka, et al.
Digestive Diseases and Sciences|January 17, 2015
Chronic hepatitis C infection as a risk factor for renal cell carcinomaHumberto C Gonzalez, Lois Lamerato, Craig G Rogers, et al.
Journal of Viral Hepatitis|June 28, 2023
Characteristics associated with receipt of treatment among patients diagnosed with chronic hepatitis C virusStuart C Gordon, Ankita Kaushik, Benjamin Chastek, et al.
Hepatology International|August 12, 2009
A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinomaRobert G Gish, Stuart C Gordon, David Nelson, et al.
Journal of Clinical Gastroenterology|December 16, 2004
The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected]Mark V Galan, Jeffrey A Potts, Ann L Silverman, et al.
Journal of Clinical Gastroenterology|March 13, 2014
Is previous exposure to hepatitis B a risk factor for pancreatic cancer or hepatocellular carcinoma?Jeffrey Tang, Rishi Sharma, Lois Lamerato, et al.
The American Journal of Managed Care|March 2, 2017
Treating Medicaid patients with hepatitis C: clinical and economic impactZobair Younossi, Stuart C Gordon, Aijaz Ahmed, et al.
The American Journal of Gastroenterology|December 14, 2019
Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare PatientsStuart C Gordon, Jeremy Fraysse, Suying Li, et al.
Pageof 22

Showing results (31-40 of 214) with videos related to

Sort By:
Pageof 22
Liver International : Official Journal of the International Association for the Study of the Liver|June 7, 2022
Response to: 'No impact of Covid-19 pandemic on decompensation of alcoholic liver disease: Results from a single Center in Milan'Humberto C Gonzalez, Loralee B Rupp, Sheri Trudeau, et al.
Hepatology (Baltimore, Md.)|July 27, 2022
Letter to the editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antiviralsSheri Trudeau, Vivek Mendiratta, Yara Dababneh, et al.
Digestive Diseases and Sciences|November 14, 2007
Bioelectrical impedance analysis for the evaluation of hepatic fibrosis in patients with chronic hepatitis C infectionFadi Antaki, M Margaret French, Dilip K Moonka, et al.
Digestive Diseases and Sciences|January 17, 2015
Chronic hepatitis C infection as a risk factor for renal cell carcinomaHumberto C Gonzalez, Lois Lamerato, Craig G Rogers, et al.
Journal of Viral Hepatitis|June 28, 2023
Characteristics associated with receipt of treatment among patients diagnosed with chronic hepatitis C virusStuart C Gordon, Ankita Kaushik, Benjamin Chastek, et al.
Hepatology International|August 12, 2009
A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinomaRobert G Gish, Stuart C Gordon, David Nelson, et al.
Journal of Clinical Gastroenterology|December 16, 2004
The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected]Mark V Galan, Jeffrey A Potts, Ann L Silverman, et al.
Journal of Clinical Gastroenterology|March 13, 2014
Is previous exposure to hepatitis B a risk factor for pancreatic cancer or hepatocellular carcinoma?Jeffrey Tang, Rishi Sharma, Lois Lamerato, et al.
The American Journal of Managed Care|March 2, 2017
Treating Medicaid patients with hepatitis C: clinical and economic impactZobair Younossi, Stuart C Gordon, Aijaz Ahmed, et al.
The American Journal of Gastroenterology|December 14, 2019
Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare PatientsStuart C Gordon, Jeremy Fraysse, Suying Li, et al.
Pageof 22